TWIST1 and breast carcinoma: There was no statistically significant difference between DFS (P = 0.174, Supplementary Fig. S5e) and OS (P = 0.170, Supplementary Fig. S5f), but the results tend to that breast cancer patients have a shorter survival when both lncATB and Twist1 were both positively expressed.